Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

NCT00064285 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: alvocidib
DRUG: imatinib mesylate

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]